Rotary stem cell culture
Culture conditions, cell density, passage history, and culture duration are optimized without T-flask culture.
Stem Cell Culture Platform
Cell Reborn LLC develops stem cell culture, stem cell culture supernatant, and conditioned medium using rotary culture instead of T-flask culture. The platform connects Miyakawa Method-based anti-proliferative evaluation against cancer cells and cell activation potential to tissue fabrication, organ repair, organ generation, research-stage countermeasure candidates for CBRNE disasters, space radiation injury, acute radiation injury, and space medicine.
About The Platform
Cell Reborn LLC integrates stem cell culture, secretome, culture conditions, and functional evaluation. Its rotary culture approach avoids T-flask culture and is designed to generate reproducible process data for future applications.
Just as emergency medicine developed through wartime military medicine, Cell Reborn views radiation-injury countermeasure research as a foundation that may support future space development and space expansion.
Capabilities
Culture conditions, cell density, passage history, and culture duration are optimized without T-flask culture.
Stem cell-derived secretome samples are prepared, compared, and evaluated under defined conditions.
In vitro anti-proliferative evaluation against cancer cells is used as a research indicator of culture-derived function.
Culture conditions, secretome, scaffolds, and evaluation systems are connected to regenerative medicine research.
The platform supports exploratory research into acute radiation injury, cell protection, and organ repair after CBRNE or space radiation exposure scenarios.
Study design, sample preparation, functional evaluation, and process planning are available for partners.
Important Scope Note
References to anti-proliferative activity against cancer cells describe in vitro research evaluation. They do not claim diagnosis, treatment, prevention, clinical efficacy, regulatory approval, or guaranteed safety.
Cell Reborn's culture-related technologies have been granted patents in Japan and the United States. Details are explained during consultation.